| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.3 | 5e-09 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.21 | 1e-08 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.25 | 2e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |